Neovascular macular degeneration is multifactorial, which requires future agents to target multiple pathways.
Sean D. Adrean, MD, FAAO
Advertisement
Articles by Sean D. Adrean, MD, FAAO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Q&A: Evolving approaches to geographic atrophy management
2
Exploring Emerging Therapies in the Retinal Vascular Disease Pipeline
3
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
4
Rates of retinal layer thinning predict visual field progression in glaucoma
5